Literature DB >> 16575680

[Cost effectiveness of V.A.C. therapy after post-sternotomy mediastinitis].

R Moidl1, T Fleck, P Giovanoli, M Grabenwöger, E Wolner.   

Abstract

Since November 2001 all patients with postoperative sternum bone infections were treated with V.A.C. therapy. The mean length of stay at intensive care unit was reduced from 9 to 1 day and reduces costs for 33 714.- USD per patient. Additionally patients who had to be closed with pectoralis muscle flap had significant reduced length of stay at ICU (1 vs 4 days, cost effectiveness 14 984.- USD per patient). The V.A.C. therapy after post-sternotomy mediastinitis significantly reduces morbidity and mortalità and is cost effective.

Entities:  

Mesh:

Year:  2006        PMID: 16575680     DOI: 10.1055/s-2006-921492

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  4 in total

Review 1.  [Vacuum-therapy of chronic wounds in dermatologic departments].

Authors:  J Dissemond
Journal:  Hautarzt       Date:  2008-08       Impact factor: 0.751

2.  Negative pressure wound therapy for the treatment of sternal wound infections after cardiac surgery.

Authors:  Tatjana Fleck; Michael Fleck
Journal:  Int Wound J       Date:  2012-09-03       Impact factor: 3.315

3.  Cost analysis of Topical Negative Pressure (TNP) Therapy for traumatic acquired wounds.

Authors:  Leila Kolios; Georg Kolios; Marius Beyersdorff; Clemens Dumont; Jan Stromps; Sebastian Freytag; Klaus Stuermer
Journal:  Ger Med Sci       Date:  2010-06-15

Review 4.  Prevention, Diagnosis and Management of Post-Surgical Mediastinitis in Adults Consensus Guidelines of the Spanish Society of Cardiovascular Infections (SEICAV), the Spanish Society of Thoracic and Cardiovascular Surgery (SECTCV) and the Biomedical Research Centre Network for Respiratory Diseases (CIBERES).

Authors:  Emilio Bouza; Arístides de Alarcón; María Carmen Fariñas; Juan Gálvez; Miguel Ángel Goenaga; Francisco Gutiérrez-Díez; Javier Hortal; José Lasso; Carlos A Mestres; José M Miró; Enrique Navas; Mercedes Nieto; Antonio Parra; Enrique Pérez de la Sota; Hugo Rodríguez-Abella; Marta Rodríguez-Créixems; Jorge Rodríguez-Roda; Gemma Sánchez Espín; Dolores Sousa; Carlos Velasco García de Sierra; Patricia Muñoz; Martha Kestler
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.